UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chipping away at the lung cancer genome

Nature medicine, 2012-03, Vol.18 (3), p.349-351

2012

Volltextzugriff (PDF)

MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation

Cell metabolism, 2017-10, Vol.26 (4), p.633-647.e7

2017

Volltextzugriff (PDF)

Comprehensive Profiling of Poor-Risk Paired Primary and Recurrent Triple-Negative Breast Cancers Reveals Immune Phenotype Shifts

Clinical cancer research, 2020-02, Vol.26 (3), p.657-668

2020

Volltextzugriff (PDF)

Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer

Cancer research (Chicago, Ill.), 2017-05, Vol.77 (9), p.2488-2499

2017

Volltextzugriff (PDF)

Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1–2 study

The lancet oncology, 2020-01, Vol.21 (1), p.134-144

2020

Volltextzugriff (PDF)

CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer

BMC cancer, 2019-01, Vol.19 (1), p.96-96, Article 96

2019

Volltextzugriff (PDF)

Nab3 nuclear granule accumulation is driven by respiratory capacity

Current genetics, 2022-12, Vol.68 (5-6), p.581-591

2022

Volltextzugriff (PDF)

Individual and Institutional Predictors of IPV/SV Screening in College Health Centers

Journal of interpersonal violence, 2021-02, Vol.36 (3-4), p.1330-1355

2021

Volltextzugriff (PDF)

Comprehensive genomic profiling of pancreatic acinar cell carcinomas identifies recurrent RAF fusions and frequent inactivation of DNA repair genes

Cancer discovery, 2014-12, Vol.4 (12), p.1398-1405

2014

Volltextzugriff (PDF)

A meta-analysis of somatic mutations from next generation sequencing of 241 melanomas: a road map for the study of genes with potential clinical relevance

Molecular cancer therapeutics, 2014-07, Vol.13 (7), p.1918-1928

2014

Volltextzugriff (PDF)

Variable penetrance of Nab3 granule accumulation quantified by a new tool for high-throughput single-cell granule analysis

Current genetics, 2022-08, Vol.68 (3-4), p.467-480

2022

Volltextzugriff (PDF)

Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)

Neuro-oncology (Charlottesville, Va.), 2022-10, Vol.24 (10), p.1776-1789

2022

Volltextzugriff (PDF)

BRAF Fusions Define a Distinct Molecular Subset of Melanomas with Potential Sensitivity to MEK Inhibition

Clinical cancer research, 2013-12, Vol.19 (24), p.6696-6702

2013

Volltextzugriff (PDF)

Antarctic Seabed Assemblages in an Ice-Shelf-Adjacent Polynya, Western Weddell Sea

Biology (Basel, Switzerland), 2022-11, Vol.11 (12), p.1705

2022

Volltextzugriff (PDF)

Parental Influences of Sexual Risk Among Urban African American Adolescent Males

Journal of nursing scholarship, 2013-06, Vol.45 (2), p.141-150

2013

Volltextzugriff (PDF)

Genetic Heterogeneity and Tissue-specific Patterns of Tumors with Multiple PIK3CA Mutations

Clinical cancer research, 2023-03, Vol.29 (6), p.1125-1136

2023

Volltextzugriff (PDF)

Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER + Breast Cancer

Clinical cancer research, 2017-10, Vol.23 (20), p.6138-6150

2017

Volltextzugriff (PDF)

ER+, HER2- advanced breast cancer treated with taselisib and fulvestrant: genomic landscape and associated clinical outcomes

Molecular oncology, 2023-10, Vol.17 (10), p.2000-2016

2023

Volltextzugriff (PDF)

Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2-, PIK3CA-mutated breast cancers

Genome medicine, 2023-04, Vol.15 (1), p.28-28, Article 28

2023

Volltextzugriff (PDF)

CBP/p300 Drives the Differentiation of Regulatory T Cells through Transcriptional and Non-Transcriptional Mechanisms

Cancer research (Chicago, Ill.), 2019-08, Vol.79 (15), p.3916-3927

2019

Volltextzugriff (PDF)

Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II Study

Targeted oncology, 2022-05, Vol.17 (3), p.283-293

2022

Volltextzugriff (PDF)

An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER2+ Breast Cancers With ERBB Ligand Overexpression

JNCI : Journal of the National Cancer Institute, 2017-11, Vol.109 (11)

2017

Volltextzugriff (PDF)

ER + Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors

Clinical cancer research, 2018-06, Vol.24 (11), p.2517-2529

2018

Volltextzugriff (PDF)

1 – 25 von 308

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(266)
Mit Volltextzugriff
(235)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(307)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(186)
Life Sciences & Biomedicine
(175)
Humans
(147)
Female
(96)
Male
(72)
Adult
(45)
Adolescent
(36)
Oncology
(36)
Social Sciences
(35)
Pediatrics
(33)
Nursing
(32)
Child
(28)
Biological And Medical Sciences
(23)
Medical Sciences
(23)
Middle Aged
(22)
Risk Factors
(22)
Animals
(21)
Infant, Newborn
(18)
Patients
(18)
Public, Environmental & Occupational Health
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Chipping away at the lung cancer genome

MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation

Comprehensive Profiling of Poor-Risk Paired Primary and Recurrent Triple-Negative Breast Cancers Reveals Immune Phenotype Shifts

Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer

Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1–2 study

CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer

Nab3 nuclear granule accumulation is driven by respiratory capacity

Individual and Institutional Predictors of IPV/SV Screening in College Health Centers

Comprehensive genomic profiling of pancreatic acinar cell carcinomas identifies recurrent RAF fusions and frequent inactivation of DNA repair genes

A meta-analysis of somatic mutations from next generation sequencing of 241 melanomas: a road map for the study of genes with potential clinical relevance

Variable penetrance of Nab3 granule accumulation quantified by a new tool for high-throughput single-cell granule analysis

Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)

BRAF Fusions Define a Distinct Molecular Subset of Melanomas with Potential Sensitivity to MEK Inhibition

Antarctic Seabed Assemblages in an Ice-Shelf-Adjacent Polynya, Western Weddell Sea

Parental Influences of Sexual Risk Among Urban African American Adolescent Males

Genetic Heterogeneity and Tissue-specific Patterns of Tumors with Multiple PIK3CA Mutations

Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER + Breast Cancer

Phase I/Ib Trial of Inavolisib Plus Palbociclib and Endocrine Therapy for PIK3CA -Mutated, Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced or Metastatic Breast Cancer

Genomic profiling of ER + breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance

ER+, HER2- advanced breast cancer treated with taselisib and fulvestrant: genomic landscape and associated clinical outcomes

Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2-, PIK3CA-mutated breast cancers

CBP/p300 Drives the Differentiation of Regulatory T Cells through Transcriptional and Non-Transcriptional Mechanisms

Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II Study

An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER2+ Breast Cancers With ERBB Ligand Overexpression

ER + Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors

Suchergebnisse filtern